5F-MDMB-PICA
|
5F-MDMB-PICA
methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate, (methyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate) |
|
| methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate | |
| Synthetic cannabinoids | |
| Synthetic cannabinoid receptor agonists |
|
|
|
InChI=1S/C21H29FN2O3/c1-21(2,3)18(20(26)27-4)23-19(25)16-14-24(13-9-5-8-12-22)17-11-7-6-10-15(16)17/h6-7,10-11,14,18H,5,8-9,12-13H2,1-4H3,(H,23,25)
|
|
CHSUEEBESACQDV-UHFFFAOYSA-N
|
|
|
CC(C)(C)C(NC(C1=CN(CCCCCF)C2=C1C=CC=C2)=O)C(OC)=O
|
|
| C21H29FN2O3 | |
| 376.465 g/mol | |
| g | |
| 71/II | |
| 2020 | |
|
This substance is included in Schedule II of the 1971 Convention on Psychotropic Substances. |